
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Page 66 of 210</i></p>
<p style="font-size: small; color: grey;"><i>Document</i></p>
<p style="font-size: small; color: grey;"><i>CNO_finacial_group_10k_066.pdf</i></p>
<p style="font-size: small; color: grey;"><i>Table of Contents</i></p>
<h2>Bankers Life (dollars in millions)</h2>

<table>
	<tr>
		<th></th>
		<th>2017</th>
		<th>2016</th>
		<th>2015</th>
	</tr>
	<tr>
		<td>Premium collections:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Annuities</td>
		<td>$ 1,030.6</td>
		<td>$ 970.0</td>
		<td>$ 803.0</td>
	</tr>
	<tr>
		<td>Medicare supplement and other supplemental health</td>
		<td>1,213.4</td>
		<td>1,235.3</td>
		<td>1,242.3</td>
	</tr>
	<tr>
		<td>Life</td>
		<td>462.4</td>
		<td>461.1</td>
		<td>446.0</td>
	</tr>
	<tr>
		<td>Total collections</td>
		<td>$ 2,706.4</td>
		<td>$ 2,666.4</td>
		<td>$ 2,491.3</td>
	</tr>
	<tr>
		<td>Average liabilities for insurance products:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Fixed index annuities</td>
		<td>$ 5,139.6</td>
		<td>$ 4,527.8</td>
		<td>$ 4,075.5</td>
	</tr>
	<tr>
		<td>Fixed interest annuities</td>
		<td>2,899.5</td>
		<td>3,188.2</td>
		<td>3,487.8</td>
	</tr>
	<tr>
		<td>SPIAs and supplemental contracts:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Mortality based</td>
		<td>160.5</td>
		<td>174.9</td>
		<td>189.5</td>
	</tr>
	<tr>
		<td>Deposit based</td>
		<td>149.0</td>
		<td>153.7</td>
		<td>153.8</td>
	</tr>
	<tr>
		<td>Health:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Long-term care</td>
		<td>4,987.4</td>
		<td>4,998.0</td>
		<td>4,916.2</td>
	</tr>
	<tr>
		<td>Medicare supplement</td>
		<td>334.9</td>
		<td>336.8</td>
		<td>331.0</td>
	</tr>
	<tr>
		<td>Other health</td>
		<td>55.9</td>
		<td>50.3</td>
		<td>47.7</td>
	</tr>
	<tr>
		<td>Life:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Interest sensitive</td>
		<td>778.2</td>
		<td>714.6</td>
		<td>643.0</td>
	</tr>
	<tr>
		<td>Non-interest sensitive</td>
		<td>1,089.9</td>
		<td>1,018.0</td>
		<td>941.5</td>
	</tr>
	<tr>
		<td>Total average liabilities for insurance products, net of reinsurance ceded</td>
		<td>$ 15,594.9</td>
		<td>$ 15,162.3</td>
		<td>$ 14,786.0</td>
	</tr>
	<tr>
		<td>Revenues:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Insurance policy income</td>
		<td>$ 1,666.6</td>
		<td>$ 1,659.1</td>
		<td>$ 1,648.7</td>
	</tr>
	<tr>
		<td>Net investment income:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>General account invested assets</td>
		<td>953.8</td>
		<td>909.5</td>
		<td>918.7</td>
	</tr>
	<tr>
		<td>Fixed index products</td>
		<td>153.5</td>
		<td>27.3</td>
		<td>(34.0)</td>
	</tr>
	<tr>
		<td>Fee revenue and other income</td>
		<td>44.1</td>
		<td>34.4</td>
		<td>27.7</td>
	</tr>
	<tr>
		<td>Total revenues</td>
		<td>2,818.0</td>
		<td>2,630.3</td>
		<td>2,561.1</td>
	</tr>
	<tr>
		<td>Expenses:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Insurance policy benefits</td>
		<td>1,448.5</td>
		<td>1,417.4</td>
		<td>1,442.5</td>
	</tr>
	<tr>
		<td>Amounts added to policyholder account balances:</td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Cost of interest credited to policyholders</td>
		<td>105.0</td>
		<td>110.8</td>
		<td>118.5</td>
	</tr>
	<tr>
		<td>Cost of options to fund index credits, net of forfeitures</td>
		<td>63.7</td>
		<td>66.1</td>
		<td>60.3</td>
	</tr>
	<tr>
		<td>Market value changes credited to policyholders</td>
		<td>154.6</td>
		<td>26.3</td>
		<td>(32.9)</td>
	</tr>
	<tr>
		<td>Amortization related to operations</td>
		<td>163.6</td>
		<td>176.5</td>
		<td>187.1</td>
	</tr>
	<tr>
		<td>Interest expense on investment borrowings</td>
		<td>19.8</td>
		<td>13.2</td>
		<td>8.8</td>
	</tr>
	<tr>
		<td>Other operating costs and expenses</td>
		<td>443.9</td>
		<td>422.1</td>
		<td>407.2</td>
	</tr>
	<tr>
		<td>Total benefits and expenses</td>
		<td>2,399.1</td>
		<td>2,232.4</td>
		<td>2,191.5</td>
	</tr>
	<tr>
		<td>Income before net realized investment gains (losses), net of related amortization, and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes</td>
		<td>418.9</td>
		<td>397.9</td>
		<td>369.6</td>
	</tr>
	<tr>
		<td>Net realized investment gains (losses)</td>
		<td>34.6</td>
		<td>(3.2)</td>
		<td>(17.2)</td>
	</tr>
	<tr>
		<td>Amortization related to net realized investment gains (losses)</td>
		<td>(1.0)</td>
		<td>(.4)</td>
		<td>.5</td>
	</tr>
	<tr>
		<td>Net realized investment gains (losses), net of related amortization</td>
		<td>33.6</td>
		<td>(3.6)</td>
		<td>(16.7)</td>
	</tr>
	<tr>
		<td>Insurance policy benefits - fair value changes in embedded derivative liabilities</td>
		<td>(3.4)</td>
		<td>10.7</td>
		<td>14.9</td>
	</tr>
	<tr>
		<td>Amortization related to fair value changes in embedded derivative liabilities</td>
		<td>7</td>
		<td>(1.3)</td>
		<td>(3.2)</td>
	</tr>
	<tr>
		<td>Fair value changes in embedded derivative liabilities, net of related amortization</td>
		<td>(2.7)</td>
		<td>9.4</td>
		<td>11.7</td>
	</tr>
	<tr>
		<td>Income before income taxes</td>
		<td>$ 449.8</td>
		<td>$ 403.7</td>
		<td>$ 364.6</td>
	</tr>
</table>
<p style="font-size: small; color: grey;"><i>66</i></p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/Assest%20 .. 7/23/2018</i></p>

</body>
</html>
